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The immune response elicited by a second injection of antigen differs markedly from 
that seen after the first injection. The initial contact with antigen results in an altered 
state  of  responsiveness, referred  to  as  immunological memory,  which  enables  the 
animal to produce antibodies more rapidly and in greater quantity. These antibodies 
are predominantly of the 7S class and are of higher affinity (1)  than those produced 
in the primary response. Memory for different classes of antibody, directed against 
the same antigenic determinants, has been shown to be carried by different cell lines 
that arise, independently, during the primary response to antigen (2, 3). 
It is now well established that the primary immune response to sheep erythrocytes 
(SRBC) in mice requires the interaction of two types of lymphoid cells, derived from 
thymus and bone marrow (4, 5). Thymus derived cells respond to an antigenic stimu- 
lus with a burst of mitotic activity (6) but do not appear capable of producing anti- 
body (7). Mitchell and Miller (8)  have shown that the ceils which produce antibody 
in  the primary  19S response are mainly of bone marrow  origin. Thus  the  antigen  7 
reactive cells (ARC)  in  the  thymus population interact with  antibody-forming cell 
precursors (AFCP) present in the bone marrow, resulting in the differentiation of the 
latter into antibody-forming cells. 
Recognizing that the immune response to SRBC requires the interaction of these 
two cell types, the difference between a primary and secondary response may be due 
to a  quantitative and/or qualitative change in either or both of these cell types. 
Studies of  the  origin of  the  antibody-forming cells are greatly facilitated by the 
use of congenic strains of mice, which differ genetically only at the loci that code for 
immunoglobnlin H  chain (or Fc) structure. The Ig-1 allotypic difference between the 
two strains (C3H. SWsnH~ and CWB), provides a marker on the 7S (~G2~) molecules 
that can be exploited to determine the number and origin of antibody producing cells, 
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by developing with appropriate  anti-allotype sera in the indirect plaque forming cell 
(PFC)  technique (9-11). 
In these experiments  we first set out to determine  whether  the thymus  cell- 
bone  marrow  cell interaction  described  for 3'M  antibody  production,  and  de- 
tected  by  H-2  (cell  membrane  antigen)  markers  (8)  is  also  necessary  for "),G 
production,  as  determined  by  immunoglobulin  allotypic marking  of the PFC. 
Having  established  that  similar  conclusions  are reached  with  both  types  of 
cell markers,  it  was  then  possible  to study  the  activity of primed  cells in  the 
adoptive  secondary  immune  response  by  injecting,  into  irradiated  recipients, 
spleen cells from immunized mice or subpopulations  of these cells obtained  by 
bovine  serum  albumin  (BSA)  gradient  centrifugation  (3),  together  with  allo- 
typically different  normal  spleen  or  bone marrow  cells.  All the 3'G~ PFC  de- 
tected in this adoptive secondary  response  were found  to be of the primed cell 
allotype. 
Materials and Methods 
Mice.--C3H.SWsnm(CSW)  mice  and  their  congenic partner  strain,  CWB  mice,  were 
used in these experiments. The genetic background  of these mice and  the means  by which 
the congenic strain was derived have been described in detail (3,  12). Donor mice were 6-8 
wk old at the time of immunization and 9-15-wk-old mice were used as recipients. In those 
experiments in which  thymectomized mice were used,  thymectomy was  performed  at  the 
age of 4-6 wk,  using a modification of the method described by Sjodin et al.  (13). The mice 
were irradiated  (see below)  1-2 wk after thymectomy and  injected intravenously with  107 
bone marrow cells,  obtained from mice of the same strain. The mice were given water con- 
taining antibiotic (neomycin-polymyxin B 1) 1 day prior to irradiation and maintained on this 
antibiotic throughout  the experiment. Absence of thymus remnants was assured at the time 
of sacrifice by macroscopic,  and  occasionally microscopic,  examination. 
Irradiallon.--Recipients  of primed  spleen  cells were given 600  rads  total  body  irradi- 
ation 4-6 hr prior to cell transfer.  Adult thymectomlzed mice received 800  rads  total body 
irradiation.  A  Siemens X-ray machine operating under  the following conditions was  used: 
250 kv, 15 ma, 0.25 mm Cu +  1.0 mm AI and a HVL (haft-value layer)  of 1.10 mm Cu.  The 
dose rate was 80 fads/rain, and the focal skin distance was 60 cm. 
Immunlzation.--In  most  experiments  donor  mice were  given a  single  intravenous  im- 
munizing injection of either 4  )  108 or 4  X  105 SRBC. The mice were sacrificed  at various 
times after SRBC injection (4-118  days)  and  their spleens  were removed. In one set of ex- 
periments the mice were given two intravenous injections of 4  X  l0 s SRBC, spaced 8 days 
apart, and their spleens were removed 6 months later. Adult thymectomized, irradiated, bone 
marrow protected mice were injected intravenously with 4  X  l0 s SRBC together with 5  X 
l0  T thymus cells  and sacrificed  8-10 days later.  Control mice did not receive thymus cells. 
In several experiments, a second  intravenous injection of 4  M  l0 s SRBC was given on day 
8 and the mice sacrificed  6 days later. 
Cell Suspemions.--Single cell suspensions  of spleen and  thymus were obtained  by gently 
1 1.13 g neomycin sulfate plus 836.2 units polymyxin B sulfate per liter, diluted in distilled, 
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pressing the tissue through a 50-mesh stainless steel screen into cold MEM-PM  ~. Clumps were 
broken up by repeated aspiration, using a Pasteur pipette, and the remaining fragments were 
allowed to settle. The supernatants were transferred, centrifuged for 10 min at 300 g at 4°C, 
and the cells resuspended in MEM-PM.  Thymus cells were given one additional washing. 
Cell counts were obtained using a Coulter counter, Model B, fitted with a 100 # aperture and 
using optimum window settings previously calibrated  with hemocytometer counts  of nu- 
cleated spleen cells. 
Bone marrow was obtained from the femurs and tibiae of 6-8-wk old mice. After cutting 
off the epiphyses, the marrow was extruded by forcing cold MEM-PM through with a syringe. 
Single cell suspensions were obtained in the manner described above. 
Cell Separation.--Cells were separated by means of the BSA density gradient centrifuga- 
tion method described by Raidt et al. (14). This method is described in detail in the preceding 
paper (3). 
Hemolytic Plaque Assay.--The numbers of direct ('yM) and indirect (')'G) PFC in spleen 
cell suspensions were determined using a modification of the hemolysis in gel technique origi- 
nally described by Jerne  et al.  (15), adapted  for microscope slides by Mishell and Dutton 
(16), and extended for development of indirect  ('yG) PFC (9-11). Total "yG PFC were de- 
veloped with polyvalent rabbit anti-mouse Ig.  Gamma G2a plaques were developed with 
mouse anti-allotype sera, which specifically  detect cells secreting antibody of this class of the 
corresponding allotype. The number  of total "),G and "}'G2a  PFC was determined by subtracting 
the number of direct PFC from the  total number of PFC developed with the antisera. A 
complete description of  the  method,  and of  the  antiallotype  sera used, has  already  been 
published (3). 
RESULTS 
Thymus-Bone Marrow Interaction in Congenic Mice.--In order to determine 
whether the  thymus-bone marrow relationship described for initiation of  the 
"vM hemolysin response (8) is also required for production of ~G antibody, the 
following experiments were set up using congenic mice. Adult thymectomized 
irradiated CWB mice, protected with 107 syngeneic bone marrow cells 1-2 wk 
previously, were injected with 5 X  107 CSW thymus cells together with 4 X  l0  s 
SRBC, and their spleens assayed 8-10 days later. In some of the experiments, 
reciprocal combinations were used. All of the mice made a  good "yM primary 
response as determined by the hemolytic plaque technique. Only a  few of the 
mice showed an increase in ~'G~a PFC sufficient to determine whether they were 
of bone marrow or thymus origin, and in these mice all ~'G2a PFC were of bone 
marrow allotype. Since no allotypic markers have yet been found for mouse 
~'M, it is essential for this type of study that a large number of ~,G antibody- 
forming cells be present in the population. In an attempt to increase the 7G2~ 
response, the remaining mice were given a  second injection of 4  X  10  s SRBC 
Minimum  Essential  Medium  (Eagle) Cat.  No.  F-12  Instant Tissue Culture Powder 
Medium without  NaHCO~ (Grand Island Biological Co., Oakland,  Calif.) made up with 
Na2HPO4" 12H~O (358 mg/liter)  and MgC12.6H20 (200 mg/liter)  instead of bicarbonate, in 
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8  days  after  the  injection of  thymus and  SRBC,  and the  spleen cells  were 
assayed 6  days later. 
It can be seen in Table I  that the thymus cell recipients made an excellent 
secondary 3~G2a response, while controls, given two injections of SRBC  only, 
made no response. All of the PFC detected were of the bone marrow allotype. 
Similar responses were obtained in a few experiments in which neonatally thy- 
TABLE I 
Origin  of  PFC  in  the  Secondary  Response  to  SRBC  after  Thymus-Bone  Marrow  Interaction, 
Determined  by  Ig  Allotype  Markers 
Recipient  Bone marrow  Thymus  Cell No. in  PFC per recipient  spleen (X 10  -~) 
strain  donor  donor  recipient  7G2a allotype  spmen  (ailotype)  (altotype)  (allotype)  (X 10-~)  3,M  (a)  (b) 
CWB (b)  CWB (b)  CSW (a)  88  23  0  29 
"  "  "  130  64  0  102 
"  "  "  95  209  0  153 
"  "  "  100  221  0  145 
"  "  "  65  62  0  126 
"  "  "  100  151  0  327 
"  "  None  43  0.34  0  0 
"  "  "  I0  1.2  0  0 
CSW (a)  CSW (a)  CWB (b)  100  359  220  0 
"  "  None  83  2  0  0 
CWB (b)*  CSW (a)  CWB (b)  100  52  53  0 
"  "  "  100  126  116  0 
"  '"  None  65  4.75  0  0 
"  ....  50  0.33  0  0 
Adult thymectomized mice were irradiated  (800 rads), protected  with 107  bone  marrow 
cells (intravenous),  and injected  intravenously  1-2 wks later  with 5  X  107  thymus cells 
together with 4 X  10  s SRBC. A second intravenous injection of 4 X  10  s SRBC was given 
8 days after  transfer,  and spleen cells were assayed 6 days later. 
* These  results  were taken from a separate experiment in which the recipients had been 
injected with anfi-allotype serum (anti-a) in an attempt to suppress the response, and are 
included only to show that the irradiated hosts do not contribute  to the response. 
mectomized mice were used.  Thus cells making 7S  antibody, at least of the 
~/G2~ class,  are derived from bone marrow cells both in the primary response 
(reported above) and in the secondary response. Moreover, both responses are 
dependent on the initial presence of thymus cells. These results are similar to 
those reported by Mitchell and Miller for the primary "yM response, using H-2 
markers (8). 
Interaction  of  Primed  Spleen  Cells  with  Bone  Marrow  Cells.--The  following 
experiments were carried out to determine whether primed cells are capable of 
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ing differentiation of these latter cells into antibody forming cells. Mice of one 
strain were injected intravenously with 4  X  10  8 SRBC and their spleens were 
removed 4-118 days after immunization.  Cell suspensions obtained from these 
spleens  were  injected  into  irradiated  mice  of  the  congenic  partner  strain 
(5  X  10  6 per mouse), either alone or together with 4  )<  10  6 bone marr¢,w cells 
from normal mice of the recipient strain.  In several experiments,  4  X  10  ~ un- 
primed spleen  cells were used in place of bone marrow cells.  Control animals 
TABLE II 
Effect  of Bone Marrow  Cells on  the Adoptive  Secondary  Immune Response  of Spleen  Cells 
from Immunized Mice 
Spleen cells 
injected* 
5 X  106 unfrac- 
tionated spleen 
cells 
$ X 106 spleen cells 
from BSA gradi- 
ent  fractions  A 
or B 
No. of bone 
marrow cells 
injected 
4  X  106 
4  X  l0 s 
No. of 
recipi- 
ent 
~nimals 
19 
20 
20 
23 
lellNo, i 
recipient 
spleen~ 
X  10-~ 
61 
(37-101) 
129 
(89-186) 
67 
(48-94) 
127 
(98-163) 
PFC per recipient spleen:~ X  10  -2 
Direct 
21 
(12-35) 
63 
(36-110) 
39 
(20-72) 
85 
(51-141) 
410 
(270-623) 
Total %'G  Primed 
__  allotype 
89  38 
(34--233)  (16-89) 
303  84 
(199-461)  (36-195) 
206  95 
(112-378)  (45-202) 
156 
(71-342) 
'G~a 
Bone marrow 
allotype 
0.1 
(0.01-1.8) 
0. I 
(0.02-1.2) 
* Spleen cells were taken from donor mice 4-118 days after immunization with 4 X  108 
SRBC. A challenge dose of 4 X  108 SRBC was given at the time of transfer. 
:~ Numbers  of cells or PFC in recipient spleen 7 days after cell transfer  are expressed as 
geometric means. Values in parentheses indicate the 95% confidence limits computed using 
appropriate  Student t-test values. 
were injected with unprimed spleen  or bone marrow  cells  alone. In all  of the 
cell transfers,  4  X  108 SRBC were injected along with these cells. 
Bone marrow cells injected with primed spleen cells  resulted in much larger 
spleens. The number of cells recovered from the spleens of these recipients 7 days 
after transfer was approximately twice that in recipients  of primed cells alone 
(Table II).  The mean values for all  classes  of PFC  determined  were  also in- 
creased approximately two-fold when bone marrow was given.  However, all of 
the ~/G2a PFC found in recipient spleens were of primed cell allotype. Similar 
results  were  obtained  when  cell  suspensions  which  had  been  enriched  for 
memory cells by BSA density gradient fractionation were used  (Table II and 
see below). 
In a few experiments 107 primed spleen cells were injected intravenously into 
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syngeneic bone marrow cells. Nonthymectomized mice, irradiated 4-6 hr before 
injection of primed cells, were used as controls. As shown in Table III, even bone 
marrow cells that had resided in the spleens of the recipients for 1 or 2 wk prior 
to primed cell transfer did not participate in the adoptive secondary response 
TABLE III 
Adoptive Secondary Immune Response of Primed  Spleen  Cells* in Mice Injected  with  Bone 
Marrow  1 or 2  Wk Previously 
Irradiation and cell injection on day: 
0  7  14 
PFC per recipient spleen* X  10  -3 
No. of  Cell No. in 
recipient  3"Gea 
recipient  spleens X  Direct  Bone 
animals  10-6  Primed 
allotype  marrow 
allotype 
800R§ 
107 bone marrow 
None 
8OOR§ 
107 bone marrow 
None 
107 primed  --  5  107  25  273 
spleen  (87-132)  (5-115)  (70-1065) 
800R[/ 
107 primed  --  3  32  51  477  0 
spleen  (16-63)  (30-86)  (298-764) 
107 primed  4  90  21  190  0 
spleen  (60-135)  (13-37)  (73-495) 
8O0R[I 
107 primed  3  35  28  402 
spleen  (19-64)  (17-45)  (385-419) 
* Spleen cell donors were given  two injections of 4  X  10  s SRBC, spaced  8 days apart, 
and the primed cells were  taken for transfer 6 months later. A challenge dose of 4  X  10 s 
SRBC  was given at the time of transfer. 
:~ Numbers of cells or PFC in recipient spleen  7 days after primed cell transfer are ex- 
pressed as geometric means.  Values in parenthesis indicate the 95%  confidence limits com- 
puted using appropriate Student t-test values. 
§ Adult thymectomized mice were  irradiated 4-6 hr before  cell injection. 
[[ Adult mice were irradiated 4-6 hr before cell injection. 
obtained. All of the 3,G.oa PFC  detected in  the spleens of these bone marrow 
restored mice were of primed cell allotype. 
Interaction of Fractionated Spleen Cells with Unprimed Spleen or Bone Marrow 
Cells.--It  was  shown  in  the  previous paper  (3)  that  fractionation  of primed 
spleen cells on a BSA density gradient resulted in an enrichment of cells carry- 
ing memory for all classes in the fractions of lowest density (A and  B).  The 
fraction  of greatest  density  (D)  contained  cells that  gave  rise  to  a  ~/M  and 
3'G1 response, but was totally depleted of cells carrying memory for "rG2a • In- 
jection of 4  X  10  ~ bone marrow cells did not lead to PFC of bone marrow allo- 
type (Table II). Changing the ratio of the two cell types by lowering the total E.  B.  JACOBSON,  J.  L'AGE-STEHR,  L.  A.  HERZENBERG  1115 
TABLE IV 
Effect  of Normal Bone Marrow or Spleen  Cells on  the Adoptive  Secondary  Immune  Response 
of BSA  Density  Gradient  Fractions  A  and  D  of Spleens from Immunized  Mice 
Injected cells* 
Total cell  PFC per recipient spleen§  >( 10T 
No. of  No. in 
recipient  recipient  ~/G~a Allotype 
mice  spleen  ~  Direct (~,M) 
×  10-6  (a)  (b) 
5  X  106 normal spleen  9  35  3 
cells (a) :~  (26-48)  (  1.6-9.1 ) 
0  0 
4  X  106  bone marrow  8  118  1 
cells  (b)  (93-151)  (0.2-6.9) 
0  0 
106 A-band cells  (a)  8  19  10  12 
(16-22)  (4.3-22)  (8.4-18) 
t06 A-band cells (a) +  8  131  40  33 
4  X  106  bone mar-  (118-145)  (25-63)  (22-57) 
row cells (b) 
0.1 
l0  s A-band cells (a) +  7  35  19  11  0.2 
4 X  106 normal  (23-51)  (12-31)  (6.3-20)  (0.01-3.4) 
spleen cells (b) 
106 D-band (a)  6  21  7  0  0 
(17-25)  (4.6-10) 
106  D-band  (a)  -[-  6  121  29  0  0.1 
4  X  106  bone mar-  (113-130)  (15-55)  (0.01-1.5) 
row cells  (b) 
106 D-band (a) -[- 4 X  6  59  26  0  0.03 
106  normal  spleen  (48-72)  (21-33)  (0.002-0.5) 
cells (b) 
* Spleen  cells  were  taken from donor mice 6  days after priming with 4  X  105  SRBC. 
The cells were injected together with 4  X  108 SRBC into recipient mice. 
:~ Letter  in  parentheses indicates Ig-1  allotype. 
§ Numbers of cells or PFC in recipient spleen 7 days after cell transfer are expressed  as 
geometric means. Values in parentheses indicate the 95% confidence  limits computed using 
appropriate student t-test values. 
number  of  spleen  cells  injected,  without  greatly  decreasing  the  number  of 
memory cells in the population, might conceivably provide a better opportunity 
for AFCP  in unprimed spleen or bone marrow to interact with these cells. In 
order to test this, 106 cells from fraction A  and from fraction D, obtained 6 days 
after priming with 4  >(  l0  n SRBC, were injected into irradiated recipients with 
and without 4  )<  106 unprimed spleen or bone marrow cells of recipient allotype, 1116  IMMUNOLOGICAL  MEMORY  IN  MICE.  II 
together with 4  X  10  8 SRBC. As seen in Table IV, injection of 10  6 A-band cells 
alone resulted in a good 3'G2~ memory response. As previously shown, the simul- 
taneous  injection  of bone  marrow  cells  had  an  enhancing  effect  on  recipient 
spleen cell numbers  and total numbers of PFC. This was also found with 4  )< 
10  6 unprimed spleen cells,  but to a much lesser degree. As in all of the previous 
experiments,  no significant numbers  Of ~/G2a PFC  of unprimed spleen or bone 
marrow cell allotype were  detected. Transfer of 10  6 D-band cells, together with 
bone marrow or unprimed spleen cells  also resulted in a greater total spleen cell 
number  and  an  enhanced 3'M  response.  The  depletion  of "gG2~ memory cells 
from this  fraction was  not  influenced  by the  addition  of unprimed  spleen  or 
bone marrow cells. 
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Fro.  1.  Number  of PFC of different classes, expressed as PFC per  106 recipient  spleen 
cells (©)  and as PFC per  recipient  spleen (O)  in mice injected  with primed  spleen cells 
(5 X  106), alone or together with bone marrow cells (4 X  106), and 4 )<  108 SRBC. Points 
represent the geometric mean of the number of PFC obtained in spleens of recipients receiving 
bone marrow relative to the numbers obtained from recipients of primed cells alone. Vertical 
bars indicate 953 confidence limits. 
A  comparison was made of the number of PFC  of each class obtained with 
and without bone marrow in individual  transfer  experiments,  calculated  both 
per 108 recipient spleen cells and per recipient spleen. Since the effect of simul- 
taneously injected bone marrow was similar  in all experiments  (see Table II), 
the results were pooled and are shown in Fig. 1, expressed as the values obtained 
with bone marrow, relative to those obtained without.  It can be seen that for 
all classes, the presence of bone marrow in these recipients resulted in a two-fold 
increase  in  PFC  when  calculated  per  recipient  spleen,  while,  in  contrast,  the 
numbers  of PFC per  10  s  cells was not significantly different than in recipients 
that  received primed  cells  alone. 
DISCUSSION 
The  data  presented  here,  using allotypic markers,  provide further  evidence 
for an interaction between thymus-derived and bone marrow derived cells in the E. B. JACOBSON,  ~[. L'AGE-STEHR,  L. A. HERZENBERG  II17 
development of an immune response against SRBC in mice. As in the ~/M re- 
sponse in which the AFCP were identified by means of H-2 markers (8), the 
~/G2a response observed in these studies was due exclusively to cells producing 
antibodies that carry the allotype of the bone marrow donor. 
Since the allotypic markers are present on the H  chain (Fc portion) of the 
immunoglobulin molecules, these results indicate that the interaction between 
thymus derived ARC and bone marrow derived AFCP is not a result of macro- 
molecular information transfer for the entire H  chain, as would be mediated by 
a mRNA (17). This possibility could not be ruled out in the experiments utiliz- 
ing H-2 membrane antigenic markers. 
Radovich et al. (18)  have reported an increase in the number of 19S PFC 
when primed spleen cells were injected together with syngeneic normal bone 
marrow cells into irradiated recipients. It was not determined in these studies 
whether the  19S PFC were of spleen or bone marrow origin, and the results 
were interpreted to be due to a nonspecific effect of bone marrow cells on the 
localization or proliferation of antibody-forming cells from the primed spleen 
inoculum. The results reported in  this paper,  with markers  on the  two cell 
types, support this interpretation. The simultaneous injection of normal bone 
marrow (or spleen) and primed spleen cells,  each of which could be identified 
by its  allotypic marker, resulted in a  significant increase in total spleen cell 
number, and also in the number of PFC per recipient spleen. In no case, how- 
ever, could any evidence be found that  would indicate that  this increase in 
PFC  was  due to a  recruitment of AFCP  in the bone marrow inoculum, re- 
sulting from an interaction with the primed spleen cells.  In every experiment, 
the ~G2a PFC that  arose during the adoptive secondary response carried the 
allotypic determinant of the primed donor cells.  This was true even in those 
experiments in which  attempts  were made  to give the bone marrow cells a 
selective advantage by using a lower number of primed cells, obtained from 
BSA density gradient fractions that  were either enriched for or depleted of 
~'G2~ memory cells. 
That the  effect of the bone marrow cells is  a  nonspecific one seems  even 
more probable if one considers that no enhancement of the response is noted 
when the results are calculated per  10  s recipient spleen cells (Fig.  1).  An en- 
hancement is seen only when the results  are calculated per recipient spleen, 
and  thus  appears  to be merely a  reflection of the  increase in  the total  cell 
number due to the bone marrow inoculum. 
The possibility has  also  been considered that bone marrow cells may not 
be able to interact  specifically with primed cells unless  they have previously 
had time to become established in the lymphoid tissue of the recipient. How- 
ever, the results obtained indicate that regardless of whether the bone marrow 
cells are injected together with primed cells or are allowed to previously settle 
in  the  recipient  spleen,  they  do  not  develop into  antibody-producing  cells. 1118  IMMUNOLOGICAL MEMORY  IN  MICE.  II 
Moreover, in the latter case, the nonspecific enhancement of the PFC response 
discussed above is not seen, possibly due to  a  limitation of biological space. 
At least three possible mechanisms for memory at the cellular level may be 
postulated. These depend on whether the primed cell population is composed of 
thymus derived cells,  bone marrow derived cells,  or both cell types. The first 
possibility is that memory cells are ARC, entirely of thymus origin, which can 
interact with any specific AFCP present in bone marrow or unprimed spleeff 
to result  in  a  secondary response.  This  possibility is  ruled  out,  at  least  for 
3'G2,, by the evidence presented here that primed cells appear to be capable 
of responding entirely on their own, in the presence or absence of additional 
bone marrow cells. The second possibility is that memory is carried entirely by 
the bone marrow cell line,  presumably following an interaction with thymus 
cells  in  the  primary response.  This  possibility  is  consistent with  the  results 
presented here and accepting it would require that there be a qualitative dif- 
ference between the  primary and secondary immune  response:  namely,  that 
the cells reacting with antigen in the secondary response be themselves able to 
become antibody-producing cells,  in contrast with the primary response where 
the ARC are thymus-derived and are not the precursors of antibody-producing 
cells.  However, our results in no way rule out the third possibility: that  the 
primed  cell  population  itself  is  made  up  of both  thymus-derived and  bone 
marrow-derived cells that interact preferentially with each other, perhaps due 
to higher affinity receptors on the surface of both cells which  compete more 
effectively for the antigen. If this is the case, then the two cell types are not 
distinguishable by their behavior on either BSA density gradients or, as shown 
previously (3), on glass bead columns. 
SUMMARY 
Congenic mice,  differing genetically only  at  the  loci  coding  for  immuno- 
globulin H  chain (or Fc) structures, have been used to study cell interactions 
in  the  7S  ('yG2~) antibody  response  to  sheep  erythrocytes (SRBC),  as  de- 
tected by the Jerne plaque-forming cell (PFC) method. 
The  interaction  between  thymus  and  bone  marrow  cells  was  studied  in 
adult  thymectomized  irradiated  recipients,  protected  with  syngeneic  bone 
marrow  and  injected  with thymus  cells  from  the  partner  congenic  strain. 
All of the ~G2~ PFC detected in the spleens of these mice were of bone marrow 
allotype. 
Adoptive  secondary  immune  responses  were  then  studied  to  determine 
whether a similar interaction between memory cells and bone marrow derived 
cells could be detected. Primed spleen cells from the partner congenic strain, or 
a subpopulation of these cells obtained by BSA density gradient fractionation, 
were injected into irradiated recipients alone, or together with syngeneic non- 
immune spleen or bone marrow cells.  All "yG~ PFC detected in these experi- E.  B.  JACOBSON~  ~I.  L~AGE-STEHR,  L.  A.  HERZENBERG  1119 
ments  were  of  primed  cell  allotype.  There  was  no  evidence  that  antibody 
forming  cell  precursors  in  normal  spleen  or  bone  marrow  participate  in  the 
adoptive secondary immune response detected 7 days after transfer of primed 
spleen  cells.  This was true regardless  of whether  the  bone marrow cells were 
injected at the time of transfer,  or were injected  1-2 wk earlier  and allowed to 
become established  in the  spleens  of recipient  mice.  Although no specific cell 
interaction  was  seen,  bone  marrow  (and,  to  a  lesser  degree,  normal  spleen) 
cells  were found to have  a  nonspecific enhancing  effect  on the  adoptive sec- 
ondary  response  when  they  were  injected  together  with  the  primed  spleen 
cells.  This  enhancement  was  not  evident  if  the  bone  marrow  cells  were  in- 
jected 1 or 2 wk prior to primed cell transfer. 
The authors thank Daniel Cahn for technical assistance and Dr. G. F. Mitchell for helpful 
discussions. 
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